Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05713890

Home-based Action Observation Treatment With Virtual-reality for Arm Rehabilitation in People With Multiple Sclerosis

Action Observation Treatment (AOT) is a rehabilitative strategy which has been proposed as a promising approach to improve motor performance in neurological conditions, including multiple sclerosis (MS).

In this clinical trial, the investigators aim to explore the role of a home-based AOT with virtual reality (VR) in improving upper limb motor function in people with MS (PwMS). The objectives are:

* To compare the effects of home-based VR-AOT versus VR-landscape observation (LO) on upper limb motor performance; * To measure brain network functional changes (functional plasticity) and structural variations of gray matter (GM) and white matter (WM) (structural plasticity) using advanced magnetic resonance imaging (MRI) techniques following VR-AOT and VR-LO; * To study the correlations between MRI changes and clinical improvements and the predictors of VR-AOT efficacy.

All participants will undergo treatment sessions for 3 weeks (5 consecutive days/week, total=15 sessions lasting 30 minutes each). Those in the VR-AOT group will observe, imagine and execute two upper limb motor tasks in each session. Those in the VR-LO group will perform the same tasks, but they will observe inanimate landscapes beforehand instead.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-65 years;
  • Diagnosis of MS according to 2017 revised McDonald criteria;
  • Ability to understand the purpose and risks of the study and provide signed informed consent;
  • Ability to remotely perform VR-AOT;
  • Right pre-morbid handedness (EHI>50);
  • Muscle strength deficit involving the right upper limb (≥1 point decrease of MRC scale);
  • Presence of activity limitation of the right hand (need of adaptations, supervision or help by another person for the execution of daily living activities according to items 1-6 of the FIM);
  • EDSS score 2.0-7.0 (inclusive);
  • Cerebellar functional system score of the EDSS ≤1;
  • Baseline 9HPT score >21 seconds and <180 seconds.

Exclusion criteria

  • MRI contraindications;
  • Significant visual deficits not allowing to observe VR stimuli;
  • Moderate to severe pain disturbances (VAS≥4);
  • Concomitant neuro-psychiatric or systemic diseases (other than MS);
  • Clinical relapses or steroid treatment in the past 3 months;
  • Modification of symptomatic treatment or botulin toxin injection in the upper limb in the past 3 months;
  • Stable disease-modifying treatment for MS for ≤6 months;
  • Rehabilitation treatment in the past 3 months.

Treatment and study plan

Home-based Action Observation Treatment with virtual-reality for upper limb rehabilitation

Other

Observation of a VR scenario depicting multiple repetitions of a specific upper limb motor task belonging to typical activities of daily living, followed by mental imagination of the action observed and then by the execution of the same task, using objects provided in a kit.

In each session, patients will watch 2 different videos and will perform the two corresponding actions. The time scheduled for observation, imagery and execution of each action will be of 5, 3, and 7 minutes, respectively, so that each session will last about 30 minutes. New actions, chosen from a dataset of 50 stimuli showing progressively increasing levels of difficulty, will be weekly administered on the basis of patient's degree of motor impairment, to involve different manual skills.

30 minutes sessions, 5 times a week for 3 consecutive weeks (15 sessions in total).

Home-based landscape observation with virtual-reality for upper limb rehabilitation

Other

Observation of virtually explorable landscapes followed by rest with eyes closed without focusing on any thought in particular and then execution of the same actions requested to VR-AOT-group. In each session, patients will explore 2 different landscapes and perform 2 different actions. The time scheduled for observation, rest and action execution will be of 5, 3, and 7 minutes, respectively, so that each session will last about 30 minutes.New actions, chosen from a dataset of 50 stimuli showing progressively increasing levels of difficulty, will be weekly administered on the basis of patient's degree of motor impairment, to involve different manual skills.

30 minutes sessions, 5 times a week for 3 consecutive weeks (15 sessions in total).

Primary outcomes

  1. Change in right hand Nine-hole peg test (9HPT)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    Time required to complete the 9HPT, a measure of hand dexterity, with the right hand (average of two tests).

Secondary outcomes

  1. Change in left hand Nine-hole peg test (9HPT)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    Time required to complete the 9HPT, a measure of hand dexterity, with the left hand (average of two tests).

  2. Change in hand grip strength

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    Hand grip strength measured with the Jamar handheld dynamometer. Measured for left and right hand separately.

  3. Change in finger tapping frequency

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    Number of taps performed with the index finger in 30 seconds (average of two trials). Measured for left and right hand separately.

  4. Change in Medical Research Council (MRC) scale

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    Segmental upper limb strength measured using the MRC scale. Scores on this scale range from 0 (no visible contraction) to 5 (normal strength). Measured for left and right upper limb separately.

  5. Change in Modified Ashworth Scale (MAS)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    Upper limb spasticity (shoulder adductors, elbow flexors, wrist flexors and pronators) measured using the MAS. Scores in this scale range from 0 (no increase in muscle tone) to 4 (affected part rigid in flexion or extension). Measured for left and right upper limb separately.

  6. Change in items 1-6 of the Functional Independence Measure (FIM)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    Autonomy in upper limb-related activities of daily living measured with items 1-6 of the FIM. Each item's score ranges from 1 (total assistance needed) to 7 (complete independence).

  7. Change in Expanded Disability Status Scale (EDSS)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    Multiple sclerosis-related global disability and functional systems subscores. Scores in this scale range from 0 (normal neurological function) to 10 (death due to multiple sclerosis).

  8. Change in Paced Auditory Serial Addition Test (PASAT)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    A cognitive task that measures sustained attention and working memory. The scores of this test, ranging from 0 to 60, are corrected for age, sex and years of education. Higher scores reflect a better performance in the test.

  9. Change in Symbol-Digit Modalities Test (SDMT)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    A cognitive task that measures information processing speed. The scores of this test, ranging from 0 to 110, are corrected for age, sex and years of education. Higher scores reflect a better performance in the test.

  10. Change in Montgomery-Asberg Depression Rating Scale (MADRS)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    An instrument that rates the severity of depressive symptoms. It is administered by a clinician through an interview. It is composed by 10 items, each with a score ranging from 0 to 6. The overall score ranges from 0 to 60, with higher scores reflecting greater severity of depressive symptoms.

  11. Change in Modified Fatigue Impact Scale (MFIS)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    A 21-item scale where patients rate their perceived feeling of fatigue in three subscales (physical, cognitive and psychosocial). The total score of this scale ranges from 0 to 84, with higher scores reflecting more impact of fatigue in everyday life.

  12. Change in Arm Function in Multiple Sclerosis Questionnaire (AMSQ)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    A self-reported measure of upper limb function containing 31 items. The score of this scale ranges from 31 to 186, with higher scores indicating more limitation in hand and arm function.

  13. Change in Multiple Sclerosis Quality of Life-54 (MSQOL-54)

    Time frame: Baseline, after 3 weeks of training and after a 3-month follow-up

    A health-related measure of quality of life in people with MS. It contains 54 items grouped in 12 subscales. Two summary scores can be extracted from this scale: the physical health and mental health composite scores. These scores can be derived from a weighted combination of scale scores (scale scores range from 0 to 100 and a higher scale score indicates better quality of life).

  14. Change in global brain volume

    Time frame: Baseline and after 3 weeks of training

    Normalized volumes of the brain, GM and WM will be extracted from 3D T1 MRI sequences.

  15. Changes in regional gray matter volumes

    Time frame: Baseline and after 3 weeks of training

    Tensor-based morphometry (TBM) will be used to map and compare longitudinal changes of regional GM volumes between groups

  16. Changes in white matter microstructural architecture

    Time frame: Baseline and after 3 weeks of training

    Tract-based spatial statistics (TBSS) will be used to map training-related changes of WM architecture.

  17. Changes in resting state functional connectivity

    Time frame: Baseline and after 3 weeks of training

    Independent Component Analysis will be used to decompose resting state functional MRI data into spatially independent maps and time courses, and to select the main sensory and motor functional networks of interest, as well as the Mirror Neuron System network.

  18. Changes in brain activation during an object manipulation task

    Time frame: Baseline and after 3 weeks of training

    Statistical Parametric Mapping (SPM) 12 will be applied to functional MRI sequences acquired during the object manipulation task to evaluate the modifications of functional activations during this task.

Study contacts

Contact information is provided by the study sponsor or research team.

Maria A Rocca, MD

CONTACT

[email protected]

0226433019 ext. 0039

Paola Valsasina, MSc

CONTACT

[email protected]

0226433944 ext. 0039

Sponsors and collaborators

Lead sponsor

IRCCS San Raffaele

Other

Collaborators

  • Istituto di Neuroscienze Consiglio Nazionale delle Ricerche

Registry information

Official study title

An Integrated and Home-based Motor Rehabilitation Combining Virtual Reality and Action Observation Treatment in People With Multiple Sclerosis: a Clinical and Neuroimaging Study

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Feb 6, 2023
Registry last updated
Dec 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.